NCT05434520

Brief Summary

The aim of this study was to assess the risk and complications after preoperative drainage of biliary obstruction in patients who underwent pancreatoduodenectomy. A retrospective cohort study of all patients who underwent pancreatoduodenectomy from January 1st, 2015 to September 30th, 2021. Patients who had preoperative bile duct drainage were compared to patients without intervention. Type of interventions, complications and outcome after surgery were compared using univariate and multivariate analysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
722

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 28, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 28, 2022

Completed
Last Updated

June 28, 2022

Status Verified

June 1, 2022

Enrollment Period

1 year

First QC Date

May 28, 2022

Last Update Submit

June 26, 2022

Conditions

Keywords

pancreatoduodenectomycomplicationspercutaneous transhepatic biliary drainage

Outcome Measures

Primary Outcomes (5)

  • Post-operative complication score (Clavien-Dindo)

    The prevalence of complications graded according to Clavien-Dindo score after pancreatoduodenectomy. Clavien-Dindo 0 is no complications, Clavien-Dindo 5 means complications resulting in mortality.

    During hospital admission, median time 13 days, up to 390 days.

  • 30-day Mortality

    30-day mortality rate post-pancreatoduodenectomy

    up to 30 days

  • 90-day Mortality

    90-day mortality rate post-pancreatoduodenectomy

    up to 90 days

  • Length of Hospital Stay

    Accumulated length of hospital stay from the admission day prior to pancreatoduodenectomy, till the day of discharge.

    Days from admission until discharge, up to 390 days, median time 13 days

  • 30-day Readmission

    Prevalence of readmission within 30-days after discharge following pancreatoduodenectomy.

    up to 30-days from hospital discharge

Secondary Outcomes (3)

  • Complications following preoperative bile duct drainage

    up to 7 days after bile duct drainage

  • Time from Bile Duct Drainage to Pancreatoduodenectomy

    Days from bile duct decompression to pancreatoduodenectomy, median time 32 days, up to 534 days

  • Histological Specimen

    Obtained within 21 days after resection

Study Arms (2)

Preoperative biliary drainage

Patients who had undergone preoperative biliary drainage (ERC og PTC) prior to pancreatoduodenectomy

Procedure: Preoperative biliary drainage (ERC og PTC-aided)

No preoperative biliary drainage

Patients who had not undergone preoperative biliary drainage (ERC og PTC) prior to pancreatoduodenectomy

Interventions

Placement of biliary stent (plastic, covered SEMS, uncovered SEMS) endoscopic by ERC or placement of plastic catheter by PTC

Preoperative biliary drainage

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients who had undergone pancreatoduodenectomy from January 1st, 2015 to September 31, 2021

You may qualify if:

  • All patients who had undergone pancreatoduodenectomy

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rigshospitalet

Copenhagen, Capitol, 2100, Denmark

Location

MeSH Terms

Conditions

Pancreatic NeoplasmsBiliary Fistula

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System DiseasesDigestive System FistulaFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 28, 2022

First Posted

June 28, 2022

Study Start

March 1, 2021

Primary Completion

March 1, 2022

Study Completion

March 1, 2022

Last Updated

June 28, 2022

Record last verified: 2022-06

Locations